Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation
The Journal of Clinical Pharmacology · 2026-09 · 66 (9)
DOI: 10.1002/jcph.70296 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 19.09.2026. Verfasst von Jordan Brooks und 16 weiteren Autor:innen. Beteiligte Einrichtung: InsightRX, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Thiotepa, Antineoplastic Agents, Alkylating. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Center for Advancing Translational Sciences and National Institutes of Health, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Thiotepa (TT) is often included in high‐dose chemotherapy prior to hematopoietic cell transplantation (HCT); however, exposure–response relationships of TT and its primary metabolite, N,N',N''‐triethylenethiophosphoramide (TEPA), remain undefined. This was a prospective study enrolling children and young adults undergoing autologous and allogeneic HCT from multiple centers. Time–concentration data were modeled using nonlinear mixed effects modeling along with clinical covariates potentially impacting pharmacokinetics. Cumulative area‐under‐the‐curve (cAUC) for TT and TEPA were derived using post hoc individual estimates for clearance. The combined cAUC TT and cAUC TEPA were also evaluated, reflecting total alkylating exposure (cAUC total ). The ratio of cAUC TT /cAUC TEPA was used to evaluate the efficiency of metabolic conversion of TT to TEPA. A total of 91 subjects were included with a median (range) actual body weight and age of 16.7 kg (4.6–110) and 4.5 years (0.23–22.5), respectively. The best fit model was a two‐compartment structure for TT, and a one‐compartment structure for TEPA. The conversion of TT to TEPA was found to be saturable at higher doses and may have important implications for optimizing exposure. Model‐based dosing, which accounts for age and body size, results in more predictive exposure as compared to conventional mg/kg dosing, particularly in the very young and obese. Next steps include evaluation of pharmacogenomics and exposure–response relationships to optimize dosing of TT in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- InsightRX, San Francisco, CA, USA.
- Center for Translational Medicine, University of Maryland, MD, USA.
- Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA, USA.
- Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, CA, USA.
- University of Minnesota Masonic Children's Hospital, University of Minnesota, Minneapolis, MN, USA.
- Department of Pediatrics, University of California Davis, Davis, CA, USA.
ORCID-Profile: Jordan Brooks, Shams Ismaeil, Maria-Stephanie Hughes, Beth Apsel-Winger, Liusheng Huang, Christine Higham, Kristina Nelson, Susie Long, Ashish Gupta, Eric Anderson, Michael A Pulsipher, Sung-Yun Pai, Janel Long-Boyle
Förderung
- National Center for Advancing Translational Sciences and National Institutes of Health
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Cancer Institute
Zitieren
APA
Brooks, J., Ismaeil, S., Hughes, M. S., Apsel-Winger, B., Lu, Y., Huang, L., Higham, C., Nelson, K., Long, S., Gupta, A., Lalefar, N. R., Anderson, E., Pulsipher, M. A., Pai, S. Y., Keizer, R. J., Dvorak, C. C., & Long-Boyle, J. (2026). Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation. The Journal of Clinical Pharmacology, 66(9). https://doi.org/10.1002/jcph.70296
Vancouver
Brooks J, Ismaeil S, Hughes MS, Apsel-Winger B, Lu Y, Huang L, et al. Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation. The Journal of Clinical Pharmacology. 2026;66(9). doi:10.1002/jcph.70296
BibTeX
@article{Brooks2026,
author = {Brooks, Jordan and Ismaeil, Shams and Hughes, Maria-Stephanie and Apsel-Winger, Beth and Lu, Ying and Huang, Liusheng and Higham, Christine and Nelson, Kristina and Long, Susie and Gupta, Ashish and Lalefar, Nahal Rose and Anderson, Eric and Pulsipher, Michael A and Pai, Sung-Yun and Keizer, Ron J and Dvorak, Christopher C and Long-Boyle, Janel},
title = {Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation},
journal = {The Journal of Clinical Pharmacology},
year = {2026},
volume = {66},
number = {9},
doi = {10.1002/jcph.70296}
}
EUVIMED